Infringement

Actions which impinge upon the monopoly granted by an Intellectual Property right are considered infringements.

(Indirect) infringement, Case Law, Infringement, Injunction, Prior use right, Revocation, Unitary Patent, UPC

(Bristows)/

In a decision issued today, the Düsseldorf Local Division has ordered the first ever permanent injunction at the UPC following a hearing on 16 May 2024. The injunction covers seven UPC member states: Austria, Belgium, Denmark, France, Italy, Luxemburg and the Netherlands. Notably, Germany was not included in the claim. The patent in question in…

Case Law, Infringement, Injunction, Inventive step, Litigation, Patents, Pharma, Pharmaceutical patent

(Bristows)/

The recent rivaroxaban PI cases may have caused you to ask yourself whether the American Cynamid principles for determining whether or not to grant preliminary injunctive relief in the UK are dead or at least dying.  In this article we consider the facts of the rivaroxaban PI applications and aim to tease out some principles…

Biologics, Brazil, Generics, Guidelines, Infringement, Pharma

(RNA Law)/

Prepared by Rob Rodrigues, Brenno Telles and Dara Offrede On Friday June 21, 2024, the government formally introduced regulations addressing the new framework for Partnerships for Productive Development (PDP). The Ministry of Health published new guidelines (Ordinance #4,472/20241) as part of the government policy to foster the “National Strategy for the Development of the Economic-Industrial…

Infringement, Netherlands, Scope of protection

(Brinkhof)/ /3 Comments

Patent claims, and therewith infringement, can get lost in translation. The Dutch first instance court limited a patent’s scope of protection based on the Dutch translation of the claims. The Court of Appeal saw it differently. A thorough review of the translation of the claims remains necessary to avoid unwanted discussions on claim interpretation. To…

(Indirect) infringement, FRAND, Infringement, Injunction, Procedure, SEP, United Kingdom

(Bristows)/

On the 23 May 2024, the English Patents Court dismissed an application by Lenovo for an interim injunction to prevent Ericsson infringing one of Lenovo’s patents pending the outcome of the UK proceedings ([2024] EWHC 1267 (Ch)). In particular, the Court found that the application failed on the basis that damages are an adequate remedy…

Equivalents, Infringement, Inventive step, Litigation, Novelty, Patents, Pharma, United Kingdom, Validity

(Bristows)/ /2 Comments

Advanced Cell Diagnostics v Molecular Instruments [2024] EWHC 898 (Pat) On 23 April 2024, Mr Justice Meade handed down his judgment in the dispute between Advanced Cell Diagnostics (ACD) and Molecular Instruments (MI). ACD is the proprietor of two European patents which relate to in situ detection of nucleic acids in single cells.  EP (UK)…

China, FRAND, Infringement, Patents, SEP

(City, University of London) and (LL.M Gujarat Maritime University)/

In December 2023, the Supreme People’s Court (SPC) of China found that Chinese consumer electronics manufacturer Oppo was responsible for infringing six Chinese standard essential patents (SEPs): 99813601.8、00815854.1、99813602.6、99813640.9、01803954.5 and 99813641.7, all related to the adaptive multi-rate wideband standard (AMR-WB) which includes audio, cellular communication, and broadband technologies. More importantly, the court established the royalty rate…

(Cross-border) jurisdiction, EPC, Infringement, Litigation, Patents, Revocation, SPC, UPC

(Bristows)/ /3 Comments

Opt-outs are dealt with in Part IV of the UPC Agreement entitled “Transitional Provisions”. The prevailing view is that these provisions should be interpreted to mean that an opted-out patent is no longer subject to the jurisdiction of the UPC and the opt out shall remain in place for the lifetime of the patent. Furthermore,…

Case Law, CJEU, Infringement, Injunction, Pharma, Pharmaceutical patent, SPC, Switzerland, Validity

(MLL Legal Ltd.)/

From the potpourri of decisions that the Swiss Federal Supreme Court handed down last year, I have selected one in subjective hindsight that I consider to be particularly relevant regarding further cases. The outcome of most decisions of the Swiss Federal Patent Court in 2023 heavily depended on the specific circumstances and the effects of…